Brittany Bradrick
Director/Board Member chez DERMATA THERAPEUTICS, INC.
Fortune : 602 $ au 31/03/2024
Profil
Brittany K.
Bradrick is currently an Independent Director at Dermata Therapeutics, Inc. and the Chief Operating & Financial Officer at Neurelis, Inc. She previously served as an Independent Director at Spectrum Pharmaceuticals, Inc. from 2022 to 2023.
From 2010 to 2016, she worked at Abbott Laboratories, Inc. as the Director of Business Development.
In 2021, she briefly held the position of Chief Operating & Financial Officer at ViaCyte, Inc. From 2016 to 2020, she was the Vice President of Strategy & Corporate Development at Insulet Corp.
She also held the position of Head of Corporate Development at Abbott Diabetes Care, Inc. Ms. Bradrick completed her undergraduate degree at the University of Missouri and earned an MBA from the Johnson Graduate School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/03/2024 | 1 465 ( 0,02% ) | 602 $ | 31/03/2024 |
Postes actifs de Brittany Bradrick
| Sociétés | Poste | Début |
|---|---|---|
| DERMATA THERAPEUTICS, INC. | Director/Board Member | 12/01/2022 |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/10/2021 |
Anciens postes connus de Brittany Bradrick
| Sociétés | Poste | Fin |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Director/Board Member | 31/07/2023 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/09/2021 |
| INSULET CORPORATION | Corporate Officer/Principal | 31/07/2020 |
Abbott Laboratories, Inc.
 Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the private company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | Corporate Officer/Principal | 01/01/2016 |
Abbott Diabetes Care, Inc.
 Abbott Diabetes Care, Inc. Medical SpecialtiesHealth Technology Abbott Diabetes Care, Inc. manufactures glucose monitoring equipments. It designs, develops and manufactures glucose monitoring systems and test strips for use in both home and hospital settings. The company was founded on August 29, 2005 and is headquartered in Abbott Park, IL. | Corporate Officer/Principal | - |
Formation de Brittany Bradrick
| University of Missouri | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| INSULET CORPORATION | Health Technology |
| Entreprise privées | 5 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
| Dermata Therapeutics, Inc. | |
Abbott Diabetes Care, Inc.
Abbott Diabetes Care, Inc. Medical SpecialtiesHealth Technology Abbott Diabetes Care, Inc. manufactures glucose monitoring equipments. It designs, develops and manufactures glucose monitoring systems and test strips for use in both home and hospital settings. The company was founded on August 29, 2005 and is headquartered in Abbott Park, IL. | Health Technology |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Health Technology |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the private company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | Health Technology |
